New York S10711 mandates that physicians offer prenatal testing for antiphospholipid syndrome as part of routine prenatal care.

New York S10711 amends the public health law to require physicians and other authorized practitioners to offer blood testing for antiphospholipid syndrome during routine prenatal care. This new requirement aims to ensure that pregnant individuals receive necessary screenings as part of their prenatal health services. The commissioner is authorized to create rules and regulations to implement these testing requirements. The act will take effect 90 days after becoming law.

New York S10711 mandates that physicians offer prenatal testing for antiphospholipid syndrome as part of routine prenatal care.

New York S10711 amends the public health law to require physicians and other authorized practitioners to offer blood testing for antiphospholipid syndrome during routine prenatal care. This new requirement aims to ensure that pregnant individuals receive necessary screenings as part of their prenatal health services. The commissioner is authorized to create rules and regulations to implement these testing requirements. The act will take effect 90 days after becoming law.